Furthermore, LC supplementation is effective in severe CPT2 deficiency [21], indicating that stopping LC supplementation may influence the activity of CPT2 in cardiomyocytes, leading to an increase in BNP levels in HD patients. The gene discussed is CPT2; the disease is Huntington disease.